Exchange Capital Management Has Lifted Kla (KLAC) Stake By $403,170; Charles River Laboratories International (CRL)’s Sentiment Is 1.03

KLA-Tencor Corporation (NASDAQ:KLAC) Logo

Exchange Capital Management Inc increased Kla (KLAC) stake by 21.61% reported in 2018Q4 SEC filing. Exchange Capital Management Inc acquired 4,530 shares as Kla (KLAC)’s stock rose 18.21%. The Exchange Capital Management Inc holds 25,490 shares with $2.28 million value, up from 20,960 last quarter. Kla now has $20.20B valuation. The stock increased 0.42% or $0.52 during the last trading session, reaching $123.43. About 809,424 shares traded. KLA-Tencor Corporation (NASDAQ:KLAC) has risen 4.95% since April 14, 2018 and is uptrending. It has outperformed by 0.58% the S&P500. Some Historical KLAC News: 19/03/2018 – KLA-Tencor: Orbotech Transaction Has Equity Value of About $3.4B; 20/03/2018 – Fitch Affirms KLA-Tencor at ‘BBB+’; Outlook Stable; 26/04/2018 – KLA-Tencor 3Q Net $306.9M; 06/03/2018 Detailed Research: Economic Perspectives on Exact Sciences, KapStone Paper and Packaging, Spirit Realty Capital, KLA-Tencor, Ne; 26/03/2018 – KLA-TENCOR CORP KLAC.O : INSTINET RAISES TARGET PRICE TO $125 FROM $110; 19/03/2018 – RPT-ORBOTECH LTD – TRANSACTION IS NOT SUBJECT TO ANY FINANCING CONDITIONALITY; 15/05/2018 – KLA-Tencor Presenting at JPMorgan Conference Tomorrow; 19/03/2018 – M&A News [Reg]: Semiconductor equipment maker KLA-Tencor buys Orbotech to find additional sources of growth; 19/03/2018 – KLA-TENCOR: TOTAL CONSIDERATION OF ABOUT $69.02/SHR; 19/03/2018 – KLA-Tencor Aims to Complete Repurchase 12-18 Months Following Orbotech Closing

Charles River Laboratories International Inc (CRL) investors sentiment decreased to 1.03 in Q4 2018. It’s down -0.22, from 1.25 in 2018Q3. The ratio fall, as 152 investment professionals started new and increased holdings, while 148 decreased and sold their positions in Charles River Laboratories International Inc. The investment professionals in our database now possess: 46.68 million shares, up from 45.21 million shares in 2018Q3. Also, the number of investment professionals holding Charles River Laboratories International Inc in top ten holdings decreased from 4 to 2 for a decrease of 2. Sold All: 18 Reduced: 130 Increased: 94 New Position: 58.

More notable recent Charles River Laboratories International, Inc. (NYSE:CRL) news were published by: Seekingalpha.com which released: “Charles River Labs extends partnership with CHDI Foundation – Seeking Alpha” on April 09, 2019, also Globenewswire.com with their article: “Report: Developing Opportunities within Bristol-Myers Squibb, AutoNation, FirstEnergy, Charles River Laboratories International, Yum! Brands, and AGNC Investment — Future Expectations, Projections Moving into 2019 – GlobeNewswire” published on March 25, 2019, Businesswire.com published: “Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference Call – Business Wire” on April 11, 2019. More interesting news about Charles River Laboratories International, Inc. (NYSE:CRL) were released by: Streetinsider.com and their article: “Lexicon Pharma (LXRX), Sanofi (SNY) Receive FDA CRL for Zynquista – StreetInsider.com” published on March 22, 2019 as well as Seekingalpha.com‘s news article titled: “Charles River Laboratories Q4 2018 Earnings Preview – Seeking Alpha” with publication date: February 12, 2019.

Since January 1, 0001, it had 0 insider buys, and 4 selling transactions for $6.45 million activity.

Analysts await Charles River Laboratories International, Inc. (NYSE:CRL) to report earnings on May, 9. They expect $1.40 earnings per share, up 1.45% or $0.02 from last year’s $1.38 per share. CRL’s profit will be $68.24 million for 25.78 P/E if the $1.40 EPS becomes a reality. After $1.49 actual earnings per share reported by Charles River Laboratories International, Inc. for the previous quarter, Wall Street now forecasts -6.04% negative EPS growth.

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. The company has market cap of $7.04 billion. It operates through three divisions: Research Models and Services , Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). It has a 31.25 P/E ratio. The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers.

The stock increased 0.12% or $0.18 during the last trading session, reaching $144.39. About 337,124 shares traded. Charles River Laboratories International, Inc. (CRL) has risen 34.55% since April 14, 2018 and is uptrending. It has outperformed by 30.18% the S&P500. Some Historical CRL News: 05/04/2018 – ANTARES PHARMA- ANNOUNCED FDA ACKNOWLEDGED RECEIPT OF RESUBMISSION TO CRL RECEIVED IN CONNECTION WITH XYOSTED NEW DRUG APPLICATION; 24/05/2018 – Charles River Non-Deal Roadshow Set By SunTrust for May. 31; 14/05/2018 – Charles River Closes Above 200-Day Moving Average: Technicals; 10/05/2018 – Charles River Labs 1Q Adj EPS $1.38; 15/05/2018 – Charles River Presenting at Bank of America Conference Tomorrow; 09/04/2018 – Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership; 26/03/2018 – Moody’s Assigns B1 To Charles River’s Unsecured Notes; Secured Term Loan Upgraded To Ba1; 26/03/2018 – APRICUS BIOSCIENCES INC – INTEND TO FURTHER CLARIFY DEFICIENCIES RAISED IN CRL AND INFORMATION THAT MAY BE NEEDED TO RESOLVE SUCH DEFICIENCIE; 18/05/2018 – AGILE THERAPEUTICS INC – IN CRL, FDA INFORMED COMPANY THAT TWIRLA NDA COULD NOT BE APPROVED; 26/03/2018 – S&PGR Rates Charles River Laboratories Sr Unsec Notes ‘BB+’

Channing Capital Management Llc holds 3.01% of its portfolio in Charles River Laboratories International, Inc. for 530,320 shares. Van Berkom & Associates Inc. owns 584,051 shares or 2.33% of their US portfolio. Moreover, Hood River Capital Management Llc has 2.08% invested in the company for 311,932 shares. The Wisconsin-based National Investment Services Inc Wi has invested 2.05% in the stock. Norris Perne & French Llp Mi, a Michigan-based fund reported 94,979 shares.

Investors sentiment decreased to 0.79 in Q4 2018. Its down 0.36, from 1.15 in 2018Q3. It dropped, as 52 investors sold KLAC shares while 203 reduced holdings. 67 funds opened positions while 134 raised stakes. 137.44 million shares or 0.76% more from 136.40 million shares in 2018Q3 were reported. Chemical Bank & Trust stated it has 0.13% in KLA-Tencor Corporation (NASDAQ:KLAC). Ent Service owns 86 shares. Umb National Bank N A Mo accumulated 2,826 shares. Lpl Ltd Liability holds 0.01% or 27,617 shares in its portfolio. Ameriprise Fincl invested in 0.05% or 1.17 million shares. Glenmede Tru Co Na holds 999,402 shares. Legal And General Group Incorporated Public Limited Liability has 839,277 shares. Petrus Tru Com Lta has 0.06% invested in KLA-Tencor Corporation (NASDAQ:KLAC). Covington Mgmt holds 0.18% of its portfolio in KLA-Tencor Corporation (NASDAQ:KLAC) for 29,613 shares. Wealthtrust Fairport Lc, Ohio-based fund reported 5 shares. Riverhead Capital Management Llc has 0.33% invested in KLA-Tencor Corporation (NASDAQ:KLAC). Ubs Asset Mgmt Americas has invested 0% in KLA-Tencor Corporation (NASDAQ:KLAC). Oaktop Ii Lp holds 9.98% in KLA-Tencor Corporation (NASDAQ:KLAC) or 400,750 shares. State Treasurer State Of Michigan reported 0.04% stake. Hillsdale Mngmt has 0% invested in KLA-Tencor Corporation (NASDAQ:KLAC) for 50 shares.

More notable recent KLA-Tencor Corporation (NASDAQ:KLAC) news were published by: Nasdaq.com which released: “KLA-Tencor (KLAC) Hits Fresh High: Is There Still Room to Run? – Nasdaq” on April 05, 2019, also Nasdaq.com with their article: “Why KLA-Tencor (KLAC) is a Great Dividend Stock Right Now – Nasdaq” published on March 28, 2019, Nasdaq.com published: “KLA-Tencor (KLAC) Prices Senior Notes to Refinance Debt – Nasdaq” on March 18, 2019. More interesting news about KLA-Tencor Corporation (NASDAQ:KLAC) were released by: Nasdaq.com and their article: “3 Semiconductor Stocks to Buy Right Now – Nasdaq” published on April 11, 2019 as well as Nasdaq.com‘s news article titled: “Validea Joel Greenblatt Strategy Daily Upgrade Report – 4/9/2019 – Nasdaq” with publication date: April 09, 2019.

Exchange Capital Management Inc decreased Industrial Select Sector Spdr(R) Etf (XLI) stake by 6,575 shares to 12,501 valued at $805,000 in 2018Q4. It also reduced Allergan Inc stake by 16,239 shares and now owns 9,134 shares. Mckesson Corp (NYSE:MCK) was reduced too.

Among 8 analysts covering KLA-Tencor (NASDAQ:KLAC), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 75% are positive. KLA-Tencor had 12 analyst reports since October 30, 2018 according to SRatingsIntel. The rating was maintained by JP Morgan on Thursday, March 7 with “Overweight”. The stock of KLA-Tencor Corporation (NASDAQ:KLAC) earned “Buy” rating by Stifel Nicolaus on Tuesday, March 5. The stock of KLA-Tencor Corporation (NASDAQ:KLAC) has “Buy” rating given on Thursday, March 7 by UBS. The firm has “Sell” rating by Goldman Sachs given on Tuesday, April 9. The company was maintained on Tuesday, March 5 by KeyBanc Capital Markets. On Thursday, March 7 the stock rating was maintained by Cowen & Co with “Buy”. As per Tuesday, October 30, the company rating was maintained by Deutsche Bank. The stock has “Buy” rating by J.P. Morgan on Thursday, March 7. The stock of KLA-Tencor Corporation (NASDAQ:KLAC) earned “Overweight” rating by KeyBanc Capital Markets on Tuesday, October 30. The stock of KLA-Tencor Corporation (NASDAQ:KLAC) has “Hold” rating given on Monday, February 25 by Deutsche Bank.

Since November 1, 2018, it had 0 insider buys, and 5 selling transactions for $1.27 million activity. Khan Ahmad A. sold $473,738 worth of KLA-Tencor Corporation (NASDAQ:KLAC) on Wednesday, November 14. $239,875 worth of stock was sold by Little Teri A. on Friday, November 23. The insider Trafas Brian M. sold $119,198. Another trade for 3,795 shares valued at $356,996 was made by Higgins Bren D. on Wednesday, November 14.

KLA-Tencor Corporation (NASDAQ:KLAC) Institutional Positions Chart